Resolve Therapeutics
CEO and Co-founder at Resolve Therapeutics, LLC.
Developing a drug for Lupus.
Launch date
Employees
Market cap
-
Enterprise valuation
€21—32m (Dealroom.co estimates Nov 2012.)
Kirkland Washington (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.0m | Series A | ||
| N/A | $1.1m | Debt | |
$5.8m | Series B | ||
| Total Funding | €7.1m | ||
Recent News about Resolve Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.